Cevostamab demonstrated a 38.8% overall response rate in relapsed/refractory multiple myeloma, with a median response duration of 12.3 months. BCMA-naive patients showed a higher overall response rate ...

Bristol Myers Squibb moves forward with its ADEPT-2 study on Cobenfy, delaying data to next year but boosting investor ...

First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

In this phase 2 study, researchers sought to determine whether cytoreductive treatment with rituximab followed by epcoritamab would deepen responses and lower risk of cytokine release syndrome.

Wave Life Sciences Ltd. ( WVE) Discusses Positive Interim Data from INLIGHT Trial of WVE-007 for Obesity December 8, 2025 8:30 AM EST ...

Cognizant is a powerhouse among New Jersey companies. Headquartered in Teaneck the business has reached more than 275,000 ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces the launch of the first-of-its-kind, ready-to-use vancomycin premix with room-temperature stability under ...

Broadcaster Park Na-rae, 40 years old, has faced allegations of receiving medical services, including intravenous injections, from a woman dubbed the “Injection Auntie,” prompting repeated criticisms ...

This article is based on TheStreet’s Stock & Markets Podcast. Hosted by Chris Versace, the veteran Wall Street investor and ...

Ms. A, dubbed the "Injection Auntie" amid allegations of illegal medical practices involving comedian Park Na-rae, has ...

"Scromiting" is a symptom of cannabinoid hyperemesis syndrome, a side effect of prolonged marijuana use that results in ...

This valuable study provides solid evidence for deficits in aversive taste learning and taste coding in a mouse model of autism spectrum disorders. Specifically, the authors found that Shank3 knockout ...